SULF2
Basic information
Region (hg38): 20:47656197-47786616
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
- not_specified (120 variants)
- not_provided (9 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the SULF2 gene is commonly pathogenic or not. These statistics are base on transcript: NM_001387048.1. Only rare variants are included in the table.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Effect | PathogenicP | Likely pathogenicLP | VUSVUS | Likely benignLB | BenignB | Sum |
---|---|---|---|---|---|---|
synonymous | 7 | |||||
missense | 113 | 120 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
Total | 0 | 0 | 113 | 11 | 3 |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
SULF2 | protein_coding | protein_coding | ENST00000359930 | 20 | 130269 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.0106 | 0.989 | 125724 | 0 | 24 | 125748 | 0.0000954 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 1.72 | 442 | 556 | 0.795 | 0.0000368 | 5733 |
Missense in Polyphen | 169 | 255.19 | 0.66225 | 2624 | ||
Synonymous | 0.255 | 225 | 230 | 0.979 | 0.0000166 | 1593 |
Loss of Function | 4.57 | 13 | 46.7 | 0.278 | 0.00000240 | 533 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000216 | 0.000210 |
Ashkenazi Jewish | 0.0000993 | 0.0000992 |
East Asian | 0.000333 | 0.000326 |
Finnish | 0.0000465 | 0.0000462 |
European (Non-Finnish) | 0.0000443 | 0.0000439 |
Middle Eastern | 0.000333 | 0.000326 |
South Asian | 0.000205 | 0.000196 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Exhibits arylsulfatase activity and highly specific endoglucosamine-6-sulfatase activity. It can remove sulfate from the C-6 position of glucosamine within specific subregions of intact heparin.;
Intolerance Scores
- loftool
- 0.0167
- rvis_EVS
- -1.59
- rvis_percentile_EVS
- 3.08
Haploinsufficiency Scores
- pHI
- 0.147
- hipred
- Y
- hipred_score
- 0.639
- ghis
- 0.510
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.665
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Sulf2
- Phenotype
- muscle phenotype; craniofacial phenotype; cellular phenotype; growth/size/body region phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); limbs/digits/tail phenotype; digestive/alimentary phenotype; vision/eye phenotype; renal/urinary system phenotype; skeleton phenotype; embryo phenotype; respiratory system phenotype; reproductive system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span);
Gene ontology
- Biological process
- kidney development;chondrocyte development;glomerular filtration;response to wounding;positive regulation of vascular endothelial growth factor production;esophagus smooth muscle contraction;positive regulation of Wnt signaling pathway;heparan sulfate proteoglycan metabolic process;glomerular basement membrane development;glial cell-derived neurotrophic factor receptor signaling pathway;negative regulation of fibroblast growth factor receptor signaling pathway;embryonic skeletal system development;cartilage development;bone development;innervation;positive regulation of canonical Wnt signaling pathway;liver regeneration;regulation of hepatocyte proliferation
- Cellular component
- extracellular space;endoplasmic reticulum;Golgi stack;plasma membrane;cell surface
- Molecular function
- arylsulfatase activity;calcium ion binding;glycosaminoglycan binding;N-acetylglucosamine-6-sulfatase activity